Vincent Lapointe

Vincent Lapointe

UNVERIFIED PROFILE

Are you Vincent Lapointe?   Register this Author

Register author
Vincent Lapointe

Vincent Lapointe

Publications by authors named "Vincent Lapointe"

Are you Vincent Lapointe?   Register this Author

15Publications

183Reads

37Profile Views

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

Eur Urol Oncol 2019 May 13;2(3):333-336. Epub 2018 Sep 13.

Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311183013
Publisher Site
http://dx.doi.org/10.1016/j.euo.2018.08.017DOI Listing
May 2019

Comparison of patient-reported outcomes with single versus multiple fraction palliative radiotherapy for bone metastasis in a population-based cohort.

Radiother Oncol 2016 05 9;119(2):202-7. Epub 2016 Apr 9.

Department of Surgery, University of British Columbia, Canada; BC Cancer Agency, Centre for the North, Prince George, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2016.03.025DOI Listing
May 2016

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.

Brachytherapy 2015 May-Jun;14(3):334-41. Epub 2015 Feb 14.

Vancouver Cancer Center, The British Columbia Provincial Prostate Brachytherapy Program, University of British Columbia, British Columbia Cancer Agency, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2015.01.001DOI Listing
December 2015

Decline in acute urinary toxicity: a long-term study in 2011 patients with prostate brachytherapy within a provincial institution.

Brachytherapy 2014 Jan-Feb;13(1):46-52. Epub 2013 Nov 7.

Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brachy.2013.10.005DOI Listing
May 2014

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival.

Int J Radiat Oncol Biol Phys 2014 Jan;88(1):87-93

Department of Surgery, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Physics, British Columbia Cancer Agency Vancouver Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016130320
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2013.10.010DOI Listing
January 2014

Biological consequences of MLC calibration errors in IMRT delivery and QA.

Med Phys 2012 Apr;39(4):1917-24

British Columbia Cancer Agency, Vancouver Cancer Centre, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1118/1.3692177DOI Listing
April 2012

Urinary symptom flare in 712 125I prostate brachytherapy patients: long-term follow-up.

Int J Radiat Oncol Biol Phys 2009 Nov 11;75(3):649-55. Epub 2009 Feb 11.

Department of Surgery, University of British Columbia, Provincial Prostate Brachytherapy Program, British Columbia Cancer Agency, 600 W. 10th Avenue, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.11.043DOI Listing
November 2009

Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP.

EMBO J 2009 Apr 5;28(8):1087-98. Epub 2009 Mar 5.

Institute for Research in Immunology and Cancer, Université de Montréal, Montréal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/emboj.2009.53DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2683702PMC
April 2009